Antidepressant Drugs and the Emergence of Suicidal Tendencies

@article{Teicher1993AntidepressantDA,
  title={Antidepressant Drugs and the Emergence of Suicidal Tendencies},
  author={Martin H. Teicher and C. Glod and J. Cole},
  journal={Drug Safety},
  year={1993},
  volume={8},
  pages={186-212}
}
SummaryAlthough antidepressant medications represent the cornerstone of treatment for patients with moderate to severe clinical depression, they also carry serious risks. There is evidence which suggests that antidepressants can, in rare instances, induce or exacerbate suicidal tendencies. Nine clinical mechanisms have been proposed through which this may occur. These are: (a) energising depressed patients to act on pre-existing suicidal ideation; (b) paradoxically worsening depression; (c… Expand
Antidepressants and suicidal risk.
TLDR
There is evidence from large international data sources and a large multicenter controlled trial that lithium prophylaxis decreases the suicide risk and overall mortality in affective disorders and a suicide-preventing effect has not been demonstrated conclusively for antidepressants or non-lithium mood stabilizers. Expand
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
TLDR
This is the first detailed report of suicidality during treatment with milnacipran, and may possibly explain the lack of any "activation syndrome", which is occasionally observed at the early stages of therapy with some antidepressants and may be linked to a temporary increase in suicidal ideation. Expand
Antidepressants and Suicide Risk: A Challenge
TLDR
Close monitoring is critical, and prudent follow-up care should be provided for patients prescribed with antidepressants, whereas others have found an increase in suicide risk during antidepressant treatment. Expand
Is there evidence for negative effects of antidepressants on suicidality in depressive patients?
  • H. Möller
  • Medicine
  • European Archives of Psychiatry and Clinical Neuroscience
  • 2006
TLDR
There seems to be only a small amount of evidence from different research approaches that antidepressants, not only serotonin reuptake inhibitors (SSRIs), might induce, aggravate or increase the risk of suicidal ideation and suicide attempts. Expand
Treatment-Associated Suicidal Ideation and Adverse Effects in an Open, Multicenter Trial of Fluoxetine for Major Depressive Episodes
TLDR
New SI was relatively common in this trial of fluoxetine and associated with the emergence of activation and overall symptomatic worsening, and whether prophylaxis against or aggressive treatment of adverse events can decrease emergence of SI merits further study. Expand
Antidepressants and suicide: risk-benefit conundrums.
TLDR
The data reviewed here make it difficult to sustain a null hypothesis that SSRIs do not cause problems in some individuals and further studies or further access to data are indicated to establish the magnitude of any risk and the characteristics of patients who may be most at risk. Expand
Do SSRIs or antidepressants in general increase suicidality?
TLDR
It is concluded that ADs, including SSRIs, carry a small risk of inducing suicidal thoughts and suicide attempts, in age groups below 25 years, the risk reducing further at the age of about 30–40 years. Expand
Suicidality, Violence, and Mania Caused by Selective Serotonin Reuptake Inhibitors: A Review and Analysis
  • P. Breggin
  • Medicine
  • Ethical Human Sciences and Services
  • 2003
TLDR
Recognition of these adverse drug reactions and withdrawal from the offending drugs can prevent misdiagnosis and the worsening of iatrogenic disorders. Expand
Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants.
  • S. Tsai
  • Medicine
  • Medical hypotheses
  • 2005
TLDR
Several possible mechanisms relating to the BDNF-dependent pathway are proposed to account for treatment-emergent suicidality and poor response to antidepressants and would help to design specific treatment strategies for depressed patients who have experienced unfavourable responses to antidepressant treatment. Expand
Antidepressant‐Induced Suicidality: An Update
TLDR
An update of the controversy surrounding antidepressants as a potential cause of suicidal ideations or behavior is provided and it appears that antidepressant‐induced suicidality appears to be an uncommon occurrence but also a legitimate phenomenon. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 223 REFERENCES
Fluoxetine: no association with suicidality in obsessive-compulsive disorder.
TLDR
The incidence of suicidality in fluoxetine-treated patients with OCD was low, compared favorably with rates in corresponding placebo- treated patients, and was well within the range of estimates in previous studies of patients with obsessive-compulsive disorder. Expand
Antidepressant induced suicidal ideation
There has long been a view that patients who are recovering from depression are at greater risk of killing themselves than patients who are severely depressed. This paradoxical response has beenExpand
The prevention of recurrent suicidal acts.
TLDR
A group of 58 high-risk patients with multiple episodes of suicidal behaviour was treated with mianserin 30 mg at night or placebo in a six month double-blind trial of the efficacy of an antidepressant in reducing suicidal behaviour. Expand
Depression and suicide.
This article is a short review of associations between depression and suicide, and formed part of a symposium held in Munich in August 1988 to discuss toxicity in antidepressive therapy. TheExpand
Lack of association between fluoxetine and suicidality in bulimia nervosa.
TLDR
Analyses of the incidence of suicidal acts and suicidal ideation did not indicate an increased risk of suicidality in patients with bulimia nervosa treated with fluoxetine compared with those treated with placebo. Expand
A preliminary trial of fluoxetine in refractory borderline patients.
TLDR
The findings from this work suggested efficacy for fluoxetine in treating the depressive and impulsive symptoms of refractory patients with borderline personality disorder. Expand
Phenobarbital treatment and major depressive disorder in children with epilepsy.
TLDR
Patients treated with phenobarbital should be closely monitored for depression, and alternative treatments should probably be sought for patients with newly diagnoses epilepsy and a personal or family history of an affective disorder. Expand
Paradoxical worsening of depressive symptomatology caused by antidepressants.
TLDR
Four cases in which antidepressant medication appeared to exacerbate a major depressive episode to the point of suicide are reported, highlighting the need for careful monitoring of symptomatology during the initial weeks of medication prescription in depressed patients. Expand
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
TLDR
Data from these trials do not show that fluoxetine is associated with an increased risk of suicidal acts or emergence of substantial suicidal thoughts among depressed patients. Expand
Drug treatment of panic disorder--a critical review of controlled clinical trials.
TLDR
Evidence does not support the hypothesis that panic-related symptomatology is a psychopathological entity, requiring a specific antidepressant drug treatment, and better compliance with benzodiazepines may favor the clinical use of these drugs rather than antidepressants. Expand
...
1
2
3
4
5
...